VERV
Sumitomo Mitsui Trust Group’s Verve Therapeutics VERV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,115,466
| Closed | -$5.44M | – | 1107 |
|
|
2024
Q2 | $5.44M | Sell |
1,115,466
-1,476,732
| -57% | -$7.21M | ﹤0.01% | 745 |
|
|
2024
Q1 | $34.4M | Buy |
2,592,198
+194,594
| +8% | +$2.58M | 0.02% | 595 |
|
|
2023
Q4 | $33.4M | Buy |
2,397,604
+250,361
| +12% | +$3.49M | 0.02% | 595 |
|
|
2023
Q3 | $28.5M | Sell |
2,147,243
-38,614
| -2% | -$512K | 0.02% | 612 |
|
|
2023
Q2 | $41M | Buy |
2,185,857
+587,863
| +37% | +$11M | 0.03% | 528 |
|
|
2023
Q1 | $23M | Buy |
1,597,994
+369,547
| +30% | +$5.33M | 0.02% | 699 |
|
|
2022
Q4 | $23.8M | Buy |
1,228,447
+452,750
| +58% | +$8.76M | 0.02% | 681 |
|
|
2022
Q3 | $26.6M | Buy |
775,697
+660,465
| +573% | +$22.7M | 0.02% | 656 |
|
|
2022
Q2 | $1.76M | Buy |
+115,232
| New | +$1.76M | ﹤0.01% | 967 |
|
|
2022
Q1 | – | Sell |
-70,950
| Closed | -$2.62M | – | 1242 |
|
|
2021
Q4 | $2.62M | Sell |
70,950
-7,471
| -10% | -$275K | ﹤0.01% | 905 |
|
|
2021
Q3 | $3.69M | Buy |
+78,421
| New | +$3.69M | ﹤0.01% | 866 |
|